JP2013515744A - 放射性医薬品錯体 - Google Patents

放射性医薬品錯体 Download PDF

Info

Publication number
JP2013515744A
JP2013515744A JP2012546241A JP2012546241A JP2013515744A JP 2013515744 A JP2013515744 A JP 2013515744A JP 2012546241 A JP2012546241 A JP 2012546241A JP 2012546241 A JP2012546241 A JP 2012546241A JP 2013515744 A JP2013515744 A JP 2013515744A
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
complex
alkyl
complex according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012546241A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013515744A5 (enExample
Inventor
フー，ジャイド
バトリン，ナサニエル，ジー．
マグダ，ダレン
Original Assignee
ルミフォア，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ルミフォア，インコーポレイテッド filed Critical ルミフォア，インコーポレイテッド
Publication of JP2013515744A publication Critical patent/JP2013515744A/ja
Publication of JP2013515744A5 publication Critical patent/JP2013515744A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Nuclear Medicine (AREA)
JP2012546241A 2009-12-24 2010-12-23 放射性医薬品錯体 Pending JP2013515744A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29015509P 2009-12-24 2009-12-24
US61/290,155 2009-12-24
PCT/US2010/062048 WO2011079291A1 (en) 2009-12-24 2010-12-23 Radiopharmaceutical complexes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017041620A Division JP2017119705A (ja) 2009-12-24 2017-03-06 放射性医薬品錯体

Publications (2)

Publication Number Publication Date
JP2013515744A true JP2013515744A (ja) 2013-05-09
JP2013515744A5 JP2013515744A5 (enExample) 2014-02-13

Family

ID=44196160

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2012546241A Pending JP2013515744A (ja) 2009-12-24 2010-12-23 放射性医薬品錯体
JP2017041620A Pending JP2017119705A (ja) 2009-12-24 2017-03-06 放射性医薬品錯体
JP2018222522A Pending JP2019052164A (ja) 2009-12-24 2018-11-28 放射性医薬品錯体
JP2020158380A Pending JP2021006542A (ja) 2009-12-24 2020-09-23 放射性医薬品錯体

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2017041620A Pending JP2017119705A (ja) 2009-12-24 2017-03-06 放射性医薬品錯体
JP2018222522A Pending JP2019052164A (ja) 2009-12-24 2018-11-28 放射性医薬品錯体
JP2020158380A Pending JP2021006542A (ja) 2009-12-24 2020-09-23 放射性医薬品錯体

Country Status (5)

Country Link
US (2) US20110189088A1 (enExample)
EP (2) EP2516407A4 (enExample)
JP (4) JP2013515744A (enExample)
AU (1) AU2010336403B2 (enExample)
WO (1) WO2011079291A1 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013519658A (ja) * 2010-02-12 2013-05-30 アルゲッタ エイエスエイ アルファ放出複合体
JP2020506163A (ja) * 2017-01-12 2020-02-27 ソシエテ・デ・プロデュイ・ネスレ・エス・アー クリプテート誘導体、及び発光ランタニド錯体としてのそれらの使用
WO2022176954A1 (ja) * 2021-02-19 2022-08-25 住友化学株式会社 放射性金属錯体及びその製造方法、並びに放射性金属捕捉剤
WO2022176961A1 (ja) * 2021-02-19 2022-08-25 住友化学株式会社 化合物及び金属錯体

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2044090B1 (en) 2006-07-10 2015-04-08 The Regents of The University of California Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides
EP2816038B8 (en) 2009-08-24 2019-12-25 Lumiphore, Inc. Hopo chelators
GB201208309D0 (en) * 2012-05-11 2012-06-27 Algeta As Complexes
WO2014078690A1 (en) 2012-11-16 2014-05-22 Lumiphore, Inc. Di-macrocycles
US11453652B2 (en) 2013-03-15 2022-09-27 Lumiphore, Inc. Di-macrocycles
AU2015244201B2 (en) * 2014-04-09 2019-09-12 Lumiphore, Inc Macrocycles
EP3237429A4 (en) * 2014-12-22 2018-08-15 Lumiphore, Inc. Functionalized linear ligands and complexes thereof
WO2017211809A1 (en) * 2016-06-10 2017-12-14 Bayer Pharma Aktiengesellschaft Radio-pharmaceutical complexes
EP3503930B1 (en) 2016-08-29 2024-12-11 Fred Hutchinson Cancer Center Chelating platform for delivery of radionuclides
WO2019246311A1 (en) * 2018-06-19 2019-12-26 Lumiphore, Inc. Macrocycle conjugates
US12134721B2 (en) 2018-10-22 2024-11-05 The General Hospital Corporation Complexes and ligands
CN117180277A (zh) * 2023-08-04 2023-12-08 中国辐射防护研究院 一种核素标记的靶向探针及其制备方法和应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05320147A (ja) * 1992-05-20 1993-12-03 Teijin Ltd ペンダント型二官能性大環状キレート配位子、その製造法および金属錯体
US5624901A (en) * 1994-04-15 1997-04-29 The Regents Of The University Of California 3-hydroxy-2(1H)-pyridinone chelating agents
JP2003523312A (ja) * 1999-02-18 2003-08-05 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 発光マーカーとして使用するためのフタルアミド−ランタニド錯体
JP2004503331A (ja) * 2000-07-04 2004-02-05 アンチキャンサー　セラピューティック　インベンションズ　エイエス 放射線治療方法
JP2005500387A (ja) * 2001-08-13 2005-01-06 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ヒドロキシピリドナート及びヒドロキシピリミジノン系のキレート剤
WO2008063721A2 (en) * 2006-08-15 2008-05-29 The Regents Of The University Of California Luminescent macrocyclic lanthanide complexes

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE561256A (enExample) * 1956-10-02
US4309305A (en) 1978-07-24 1982-01-05 The United States As Represented By The United States Department Of Energy In vitro removal of actinide (IV) ions
US4543213A (en) 1978-07-24 1985-09-24 The United States Of America As Represented By The United States Department Of Energy Process for preparing 2,3-dihydroxybenzoic acid amides of tetraazaalkanes and cycloalkanes
US4181654A (en) * 1978-07-24 1980-01-01 The United States Of America As Represented By The United States Department Of Energy 2,3-Dihydroxybenzoic acid amides of tetraazaalkanes and tetaaza cycloalkanes
US4442305A (en) * 1981-08-24 1984-04-10 The United States Of America As Represented By The United States Department Of Energy Polycatecholamide chelating agents
US4748184A (en) * 1982-07-26 1988-05-31 E. I. Du Pont De Nemours And Company Aryl substituted aminomethyl benzene derivatives having antiarrhythmic utility
GB8325494D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
US5010191A (en) 1985-08-19 1991-04-23 The Regents Of The University Of California Imaging agents for in vivo magnetic resonance and scintigraphic imaging
US4698431A (en) 1985-11-12 1987-10-06 The United States Of America As Represented By The United States Department Of Energy Hydroxypyridonate chelating agents
US4855225A (en) * 1986-02-07 1989-08-08 Applied Biosystems, Inc. Method of detecting electrophoretically separated oligonucleotides
US4868103A (en) * 1986-02-19 1989-09-19 Enzo Biochem, Inc. Analyte detection by means of energy transfer
US5047519A (en) * 1986-07-02 1991-09-10 E. I. Du Pont De Nemours And Company Alkynylamino-nucleotides
US4978614A (en) * 1988-10-26 1990-12-18 Tropix, Inc. Method of detecting a substance using enzymatically-induced decomposition of dioxetanes
US4939254A (en) * 1988-04-26 1990-07-03 The Regents Of The University Of California Template synthesis of macrocyclic catecholamide complexes
SE8801702D0 (sv) * 1988-05-05 1988-05-05 Pharmacia Ab Sett vid bestemning av enzymatisk aktivitet
IL90730A0 (en) * 1988-06-24 1990-01-18 Dow Chemical Co Macrocyclic bifunctional chelants,complexes thereof and their antibody conjugates
US5049280A (en) 1989-03-29 1991-09-17 The Regents Of The University Of California 2,3-dihydroxyterephthalamides as highly effective metal ion sequestering compounds
JPH07501058A (ja) * 1991-11-08 1995-02-02 キュレイターズ　オブ　ザ　ユニヴァーシティー　オブ　ミズーリー 治療または診断用の放射性薬品の像形成剤の設計における潜在的な使用のための新規な多官能リガンド
US5739294A (en) * 1991-12-10 1998-04-14 The Dow Chemical Company Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents
AU670108B2 (en) * 1992-09-11 1996-07-04 Becton Dickinson & Company Improved antibodies to plasmodium falciparum
TW275070B (enExample) * 1992-12-22 1996-05-01 Ciba Geigy Ag
US5482698A (en) 1993-04-22 1996-01-09 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin polymer conjugates
DE19525924A1 (de) * 1995-07-04 1997-01-09 Schering Ag Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
US7745142B2 (en) * 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US5989823A (en) * 1998-09-18 1999-11-23 Nexstar Pharmaceuticals, Inc. Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
US5998146A (en) * 1998-07-17 1999-12-07 Wallac Oy Homogeneous luminescence assay method based on energy transfer
DK1154991T3 (da) * 1999-02-18 2004-11-22 Univ California Salicylamid-lanthanidkomplekser til anvendelse som luminescerende markörer
US6221476B1 (en) * 1999-06-11 2001-04-24 Ibc Advanced Technologies, Inc. Polymeric membranes functionalized with polyhydroxypyridinone ligands
AU2002236683A1 (en) * 2000-10-27 2002-05-21 Beth Israel Deaconess Medical Center Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates
US20040034223A1 (en) * 2002-02-07 2004-02-19 Covalent Partners, Llc. Amphiphilic molecular modules and constructs based thereon
US20060228297A1 (en) * 2003-04-15 2006-10-12 Roy Larsen Thorium-227 for use in radiotherapy of soft tissue disease
EP1684808B1 (en) * 2003-11-07 2013-01-09 Newport Instruments A reagent system and method for modifying the luminescence of lanthanide(iii) macrocyclic complexes
DE602004016390D1 (en) * 2003-12-30 2008-10-16 Univ California Office Of The Aromatische triamid-lanthanid-komplexe
CA2570191C (en) * 2004-06-25 2015-04-28 The European Community, Represented By The European Commission Radionuclides for medical use
US7794691B2 (en) * 2004-06-25 2010-09-14 The European Community, Represented By The European Commission Radionuclides for medical use
EP2044090B1 (en) * 2006-07-10 2015-04-08 The Regents of The University of California Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides
WO2008092120A1 (en) * 2007-01-25 2008-07-31 Lumiphore, Inc. Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes
FR2936245B1 (fr) * 2008-09-23 2012-07-06 Cis Bio Int Nouveaux substrats d'o6-alkylguanine-adn alkyltransferase et ses mutants.
US20100151591A1 (en) * 2008-10-31 2010-06-17 Butlin Nathaniel G Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
WO2010129962A2 (en) * 2009-05-08 2010-11-11 The Regents Of The University Of California Combination treatment of hydroxypyridonate actinide/lanthanide decorporation agents
EP2816038B8 (en) * 2009-08-24 2019-12-25 Lumiphore, Inc. Hopo chelators
US20120190012A1 (en) * 2010-04-06 2012-07-26 Lumiphore, Inc. Compositions and methods for dna sequencing

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05320147A (ja) * 1992-05-20 1993-12-03 Teijin Ltd ペンダント型二官能性大環状キレート配位子、その製造法および金属錯体
US5624901A (en) * 1994-04-15 1997-04-29 The Regents Of The University Of California 3-hydroxy-2(1H)-pyridinone chelating agents
JP2003523312A (ja) * 1999-02-18 2003-08-05 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 発光マーカーとして使用するためのフタルアミド−ランタニド錯体
JP2004503331A (ja) * 2000-07-04 2004-02-05 アンチキャンサー　セラピューティック　インベンションズ　エイエス 放射線治療方法
JP2005500387A (ja) * 2001-08-13 2005-01-06 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ヒドロキシピリドナート及びヒドロキシピリミジノン系のキレート剤
WO2008063721A2 (en) * 2006-08-15 2008-05-29 The Regents Of The University Of California Luminescent macrocyclic lanthanide complexes

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
C. R. CHIMIE, vol. 10, JPN6015001037, 2007, pages 1010 - 1019, ISSN: 0003266269 *
HORST KUNKELY ET AL: "Photoluminescence of thorium(IV) 2-methyl-8-quinolinolate", CHEM. PHYS. LETT., vol. vol.304, no.3-4, JPN6016007643, 30 April 1999 (1999-04-30), pages 187 - 190, ISSN: 0003266267 *
NORMAN M. EDELSTEIN ET AL: "Optical properties of Cm(III) in crystals and solutions and their application to Cm(III) speciation", COORD. CHEM. REV., vol. vol.250, no.7-8, JPN6016007640, 6 March 2006 (2006-03-06), pages 948 - 973, ISSN: 0003266266 *
XU,J. ET AL: "An eight-coordinate cage: synthesis and structure of the first macrotricyclic tetraterephthalamide", INORGANIC CHEMISTRY, vol. 31, no. 24, JPN6016007645, 25 November 1992 (1992-11-25), pages 4903 - 5, ISSN: 0003266268 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013519658A (ja) * 2010-02-12 2013-05-30 アルゲッタ エイエスエイ アルファ放出複合体
JP2020506163A (ja) * 2017-01-12 2020-02-27 ソシエテ・デ・プロデュイ・ネスレ・エス・アー クリプテート誘導体、及び発光ランタニド錯体としてのそれらの使用
WO2022176954A1 (ja) * 2021-02-19 2022-08-25 住友化学株式会社 放射性金属錯体及びその製造方法、並びに放射性金属捕捉剤
WO2022176961A1 (ja) * 2021-02-19 2022-08-25 住友化学株式会社 化合物及び金属錯体

Also Published As

Publication number Publication date
EP2516407A1 (en) 2012-10-31
JP2021006542A (ja) 2021-01-21
US20200024234A1 (en) 2020-01-23
EP2516407A4 (en) 2013-06-12
WO2011079291A1 (en) 2011-06-30
AU2010336403A1 (en) 2012-06-28
EP3263562A1 (en) 2018-01-03
AU2010336403B2 (en) 2016-04-21
JP2019052164A (ja) 2019-04-04
US20110189088A1 (en) 2011-08-04
JP2017119705A (ja) 2017-07-06

Similar Documents

Publication Publication Date Title
JP2019052164A (ja) 放射性医薬品錯体
EP3129350B1 (en) Macrocycles
US20240067650A1 (en) Macrocyclic ligands with pendant chelating moieties and complexes thereof
JP7744952B2 (ja) ペンダントキレート部分を有する大環状リガンドおよびその錯体
US10434186B2 (en) Functionalized linear ligands and complexes thereof
WO1998043678A2 (en) Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy
EP2920157B1 (en) Di-macrocycles
US11453652B2 (en) Di-macrocycles
WO2023150540A1 (en) Hydroxamic acid macrocyclic agents with pendant chelating moieties and complexes thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131220

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20131220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20131224

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150205

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150422

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150602

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150701

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150805

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160229

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160530

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160722

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160829

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20161104

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170306

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170412

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20170511

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20170714

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180406

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180605